http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102512378-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_86f9fd708fb86712e0772b8311214e17 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4015 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12 |
| filingDate | 2011-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bdcffe9cb34ee64c8aa08e69d2fe9ee8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0433f9d00caf75e90f8af560ea35f098 |
| publicationDate | 2014-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102512378-B |
| titleOfInvention | Stable and safe oxiracetam pharmaceutical composition for injection |
| abstract | The invention relates to a stable and safe oxiracetam pharmaceutical composition for injection and a preparation method thereof, especially to an oxiracetam pharmaceutical composition for treating brain damage and neurological deficit caused by the brain damage as well as impediment of anamnesis and aptitude. Preferred are injections and lyophilized powders. The oxiracetam pharmaceutical composition provided by the invention mainly contains active components of oxiracetam, sodium chloride and citric acid. The oxiracetam pharmaceutical composition for injection has stable pH values and low impurity content. By the adoption of the preparation method, curative effects of the product are effectively raised, side effects are minimized, and simultaneously the yield is raised, cost is reduced, and higher benefits are created. |
| priorityDate | 2011-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 41.